Chief Executive Officer
Mr. Pedlar has been President and Chief Executive Officer of the Corporation since April 3, 2010 and a member of the Board of Directors since January 14, 2010. Previously, Mr. Pedlar was President of Pedlar Ventures Limited, a private venture investment and consulting firm based in Oakville, Ontario. He has served in senior executive positions with public companies including temporary Chief Financial Officer, Cygnal Technologies Corp., October 2007; President, Cedara Software Corp., 2005 to 2006; Chief Financial Officer, Cedara Software Corp., 2004 to 2005; and Director of Finance, Cedara Software Corp., 2000 to 2004. Mr. Pedlar has also held senior executive positions with Merge Healthcare and IMAX Corporation. Mr. Pedlar holds a Bachelor of Science degree from Mount Allison University, a post-graduate diploma in Accounting from Wilfrid Laurier University and is a Canadian Chartered Accountant.
Dr. Val DiTizio
Chief Scientific Officer
Dr. DiTizio is a co‐inventor of Covalon technologies and a co‐founder of the company. He has degrees in science from the University of Toronto as a Biochemistry Specialist. Dr. DiTizio completed his Master's degree in liposome drug delivery. His graduate research involved the application of polymer chemistry and drug delivery in pursuit of novel materials and processes that currently comprise the core of Covalon’s intellectual property. Dr. DiTizio holds several US and European patents.
Chief Financial Officer
Mr. Brannagan has been managing Covalon’s finance team since joining the Company in November 2014. Mr. Brannagan is a Chartered Accountant and Certified Professional Accountant and holds a Bachelors of Commerce degree from Queen's University. Prior to joining Covalon, Danny spent several years with PriceWaterhouse Coopers LLP in the tax and assurance groups advising public and private companies on taxation and financial accounting matters. Prior to joining PriceWaterhouse Coopers LLP Mr. Brannagan was a professional football player with the Toronto Argonauts where he became the first Canadian-born quarterback to play for the Argonauts since 1969.
Vice President of Operations
Kim has over 20 years’ cross-disciplinary experience in the pharmaceutical and Medical device industries with international and Canadian companies including Baxter, Bristol-Myers Squibb and Vasogen. Kim has extensive Quality Assurance, Quality Control, Regulatory and Clinical Affairs experience in the US, Canada and the EU. Kim joined Covalon Technologies in 2008 and has been improving internal communications and promoting customer relationships. Kim has built up and led cross functional teams to ensure projects meet Customer expectations as well as streamlining the work flow to improve the efficiency and productivity. Kim holds a Bachelor of Science degree from Carleton University.
Vice President of Human Resources
Joining Covalon in 2018, Mr. Leszczynski brings with him over 20 years of experience in Human Resources within the technology, healthcare, and financial industries. He has broad experience in all key HR areas, has experience managing global Human Resources and practices, and has a passion for developing leadership within organizations. Throughout his career, Mr. Leszczynski has held various progressive HR positions, including Vice President of Human Resources at Merge Healthcare. Mr. Leszczynski holds an Honours Bachelor of Science from the University of Toronto and is a Certified Human Resources Leader (CHRL).
Vice President of Marketing
VP of Marketing with over 17 years of experience in medical device industry with both capital equipment and consumables technologies, focused in areas of lab research and diagnostics in addition to medication administration and management in acute care. She brings with her, a Masters of Business Administration from Schulich School of Business, including an exchange abroad at Bocconi University in Milan, Italy. Prior to Covalon Technologies, Alyssa has held various marketing and leadership roles at Cardinal Health, CareFusion and BD.